Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Maria Ester Dominguez"'
Autor:
Julian Iturbe, Carlos Teodoro Vallejo, Bernardo Amadeo Leone, Jose Pablo Leone, G. Grosman, Maria C. Mac Donnell, J E Perez, Julieta Leone, Maria Ester Dominguez, Ariel Osvaldo Zwenger
Publikováno v:
The International Journal of Biological Markers. 31:300-308
Background Several mechanisms are involved in the development of resistance to therapy in locally advanced cervical squamous cell carcinoma (LACSCC). Studies have shown that CD44 and Lewis Y antigen (LeY) form a complex that is associated with chemor
Autor:
Maria Ester Dominguez, Ariel Osvaldo Zwenger, Jose Pablo Leone, Julian Iturbe, A Romero, Julieta Leone, E. H. Ortiz, Hebe Margot Fasce, M Machiavelli, Mario Langui, Luis A. Romero Acuña, J E Perez, Carlos Teodoro Vallejo, Bernardo Amadeo Leone
Publikováno v:
Breast Cancer Research and Treatment. 143:313-323
Neoadjuvant chemotherapy (NAC) allows direct evaluation of the tumor's sensitivity to therapy, eradication of micrometastatic disease and the possibility of performing breast conserving surgery. The aim of this study was to describe long-term results
Autor:
S. Amato, Juan M. Romero Acuna, Luis Flores Acosta, Eduardo H. Ortiz, A Romero, M Machiavelli, Maria Ester Dominguez, Nora Marrone, Hebe Margot Fasce, M. J. Langhi, Carlos Teodoro Vallejo, Luis A. Romero Acuña, J E Perez, Fabrina Bologna, J. A. Lacava, Bernardo Amadeo Leone
Publikováno v:
American Journal of Clinical Oncology. 25:383-387
A phase II trial was performed to evaluate the efficacy and toxicity of the novel combination of vinorelbine and paclitaxel as first-line chemotherapy in patients with stages IIIB and IV non-small-cell lung cancer. From January 1997 to September 1999
Biochemical Modulation of 5-Fluorouracil by Methotrexate in Patients With Advanced Gastric Carcinoma
Autor:
Eduardo H. Ortiz, J E Perez, R. Rodriguez, Bernardo Amadeo Leone, Carlos Teodoro Vallejo, M. R. Barbieri, Luis A. Romero Acuña, Maria Ester Dominguez, M Machiavelli, A Romero, J. A. Lacava, Juan M. Romero Acuna, M. J. Langhi
Publikováno v:
American Journal of Clinical Oncology. 21:452-457
A phase II trial was conducted to evaluate the efficacy and toxicity of a modulation of 5-fluorouracil (5-FU) by methotrexate (MTX) (with leucovorin (LV) rescue) as first-line chemotherapy in patients with locally advanced (inoperable) or metastatic
Autor:
R. Rodriguez, M A Cuevas, C. L. Sabatini, J. A. Lacava, Bernardo Amadeo Leone, L A Acuña, M Machiavelli, Maria Ester Dominguez, M. A. Salvadori, E. H. Ortiz, Carlos Teodoro Vallejo, J M Acuña, M. J. Langhi, M R Barbieri, S. Amato, J E Perez, A Romero
Publikováno v:
Journal of Clinical Oncology. 14:2993-2999
PURPOSE To evaluate the efficacy and toxicity of the combination of ifosfamide (IFX) and vinorelbine (VNB) as first-line chemotherapy in metastatic breast cancer (MBC). PATIENTS AND METHODS Between August 1993 and August 1995, 45 patients with untrea
Autor:
Jose Pablo Leone, Maria C. Mac Donnell, Julian Iturbe, G. Grosman, Maria Ester Dominguez, Ariel Osvaldo Zwenger, J E Perez, Julieta Leone, Bernardo Amadeo Leone, Carlos Teodoro Vallejo
Publikováno v:
Journal of Clinical Oncology. 33:e16590-e16590
e16590 Background: Several mechanisms are involved in the development of resistance to therapy in LACSCC. Studies have shown that CD44 and Lewis Y antigen (LeY) form a complex that is associated wi...
Autor:
Luis A. Romero Acuña, Maria Ester Dominguez, A Romero, M. J. Langhi, M. R. Barbieri, M Machiavelli, Mirna Scenna, Focaccia G, J E Perez, Carlos Teodoro Vallejo, J. A. Lacava, Eduardo H. Ortiz, R. Rodriguez, Sergio Grasso, Bernardo Amadeo Leone, Guillermo Suttora, Juan M. Romero Acuna, S. Amato, José M. Boughen
Publikováno v:
American journal of clinical oncology. 23(5)
A phase II trial was performed to assess the efficacy and toxicity of a combination of ifosfamide (IFX), cisplatin (CDDP), and vinorelbine (VNB) as neoadjuvant chemotherapy (NAC) for untreated advanced cervical carcinoma (ACC). Between October 1995 a
Autor:
Luis A. Romero Acuña, Mario Langui, M Machiavelli, E. H. Ortiz, Hebe Margot Fasce, Jose Pablo Leone, J E Perez, Bernardo Amadeo Leone, Julian Iturbe, Julieta Leone, Maria Ester Dominguez, Ariel Osvaldo Zwenger, Carlos Teodoro Vallejo, A Romero
Publikováno v:
Journal of Clinical Oncology. 31:1073-1073
1073 Background: Neoadjuvant chemotherapy allows direct evaluation of the tumor’s sensitivity to therapy, eradication of micrometastatic disease and the possibility of performing breast conserving surgery. The aim of this study was to describe long
Autor:
Carlos Teodoro Vallejo, E. H. Ortiz, M Machiavelli, Julian Iturbe, Maria Ester Dominguez, J E Perez, Ariel Osvaldo Zwenger, Mario Langui, Hebe Margot Fasce, Luis A. Romero Acuña, Bernardo Amadeo Leone, Jose Pablo Leone, Julieta Leone, A Romero
Publikováno v:
Journal of Clinical Oncology. 31:11118-11118
11118 Background: Neoadjuvant chemotherapy is a standard treatment in stage III breast cancer. Prognostic factors can help to identify patients (pts) with high risk of recurrence. The aim of this study was to assess several prognostic factors after a
Autor:
A Romero, Carlos Teodoro Vallejo, M Machiavelli, Julian Iturbe, R. Rodriguez, Bernardo Amadeo Leone, Maria Ester Dominguez, J. A. Lacava, Ariel Osvaldo Zwenger, J E Perez
Publikováno v:
Journal of Clinical Oncology. 25:14536-14536
14536 Background: The role of metastatic site in MCCID is unclear. The goal of this study is to evaluate if metastatic site influence survival in this setting of patients (P). Methods: Analyses were based on individual data of 300 P with MCCID treate